Jiangsu Hengrui Pharmaceuticals’ License Agreement With Elevar Therapeutics

Laura Testa Asia & Pacific Legal Chronicle
Tagged:

Cooley advised Jiangsu Hengrui Pharmaceuticals on the deal.Jiangsu Hengrui Pharmaceuticals (“Hengrui”), a global pharmaceutical company focused on scientific and technological innovation, signed a global license agreement (excluding…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here